Market Place
Sourcing Support
All News #Library
Biotech
Biosion Launches Phase 1 Trial of BSI-082 for Advance Solid Tumor
03 Feb 2026 //
PR NEWSWIRE
Biosion Names Kedan Lin, Ph.D., Chief Development Officer
19 Feb 2025 //
PR NEWSWIRE
Aclaris Therapeutics Announces Global License Agreement with Biosion
18 Nov 2024 //
GLOBENEWSWIRE
Biosion Announces Global License with Aclaris for Immunology Assets
18 Nov 2024 //
PR NEWSWIRE
OBI Pharma Announces FDA Clearance of IND Application for a Phase 1/2 of OBI-992
08 Jan 2024 //
PR NEWSWIRE
Biosion Announces Phase II Study Start for Anti-TSLP mAb BSI-045B
31 Jul 2023 //
PR NEWSWIRE
Biosion Initiates Phase II Clinical Trial of BSI-045B in Atopic Dermatitis
04 Apr 2023 //
PR NEWSWIRE
Biosion bispecific antibody therapies to be featured at AACR meeting 2023
22 Mar 2023 //
PR NEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.